Left to right: Ms. Sion Hau, Ms. Maryam Siddique, Dr. Louiza Chitour, Ms. Kawthar Bukhari, Mr. Scott VanderMeer and Mr. Mehrab Ajalli
Dubai, UAE and Durham, NC. November 12, 2022 – Infusion 51a, an impact investment fund based in the United States and expanding to the MENA Region, participated on November 12-13th in the second edition of the Dubai Healthcare Future Summit (HFS), an event with the goal to boost healthcare industry collaborations and breakthroughs.
The conference was held at the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU). This year’s edition was focused on Occupational Health, Maritime Healthcare, Travel Safety & Aerospace Medicine, Start-ups and Healthcare Disruptions, Leadership in Healthcare, Pharma in Healthcare, Patient Safety, Point of Care: Post Pandemic lifestyle Journey and Healthcare Innovation & Technology.
Besides conferences on changes healthcare should and will face to improving the possibilities for patients worldwide, other relevant panels included women leadership in healthcare and how their representation is key to moving the industry forward.
Scott VanderMeer, General Partner of Infusion 51a, commented about the two-day experience: “Healthcare Future Summit was a nurturing event with hundreds of KOL’s taking place in conversations everyone within healthcare and life-sciences should be having. We’re glad to have been part of it and look forward to many more conferences in the MENA Region around healthcare innovations.”
Mehrab Ajalli, Director of Strategic Growth in the MENA region and who also attended HFS, added: “The mindset of our fund is to help as many patients as possible and so was everyone who attended the Healthcare Future Summit. We hope to take action as a community in many of the addressed topics before HFS 2023.”
For the third time this year, Infusion 51a’s US leadership is on a business trip in the Middle East. VanderMeer and Ajalli will be in different cities in the UAE, Saudi Arabia, and Bahrain to attend further meetings and conferences during November and early December.
Upcoming events and locations
- MENA Angel Investors Summit (Nov 14) | Bahrain
- Abu Dhabi Finance Week (Nov 15-18) | Abu Dhabi, ADGM
- Formula 1 Race (Nov 19) | Abu Dhabi
- World Champion Golf Tournament (Nov 20) | Dubai
- Nurses & Allied Health Care Conference (Nov 21-23) | Sharjah
- International Indo-Arab Conference in Medicine 2022 (Nov 26-27) (Invited by his HE Ahmed Elmetwally) | Dubai
- Hosting meetings (Nov 24-25) | Dubai
- Conrad Etihad Towers – Emirates Oncology Conference (Nov 25-27) | Abu Dhabi
- Hosting meetings (Dec 4-6) | Saudi Arabia
Infusion 51a expanded its operations to the Middle East during the first quarter of 2022 and has been working closely with top-tier institutions to bolster healthcare technology in the Region. If you would like to have an in-person meeting with them to learn how Infusion 51a can help you, click here.
About Infusion 51a
Infusion 51a is an impact investment fund focused on Healthcare and Biotech while leveraging the booming industry of Precision Medicine. Precision medicine is a turning point within the Healthcare sector, with digital technologies and artificial intelligence leading to unprecedented opportunities for drug discovery and development. The fund has several oncological assets under management derived from its diversified portfolio of clinical-stage companies.
About Dubai Healthcare Future Summit
The aim of the Healthcare Future Summit is to define the niche by reshaping growth strategies in order to ensure greater impact on collaborations between industry leaders and regulators in the healthcare industry, both public and private sectors. Design systems that support the healthcare industry after the COVID-19 Pandemic and prepare it for any unforeseen future circumstances. Rethink innovation and its impact on business models and social systems in an ever-challenging environment.
For more information, visit https://hfs.ae.